Finance

Lists
6667:HKG
Mega Genomics Ltd
HK$7,19
-0,42%
(-0,030) 1D
16 Okt., 16:00:00 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6667...
Open
HK$7,22
High
HK$7,24
Low
HK$7,16
Mkt. cap
1,59 mjd
Avg. vol.
105,63 k
Volume
119,20 k
Dividend
2,36%
Quarterly dividend
HK$0,04
P/E ratio
51,17
52-wk high
HK$7,53
52-wk low
HK$5,00
EPS
HK$0,14
Shares outstanding
224,30 m
No. of employees
196
Open
HK$7,22
High
HK$7,24
Low
HK$7,16
Mkt. cap
1,59 mjd
Avg. vol.
105,63 k
Volume
119,20 k
Dividend
2,36%
Quarterly dividend
HK$0,04
P/E ratio
51,17
52-wk high
HK$7,53
52-wk low
HK$5,00
EPS
HK$0,14
Shares outstanding
224,30 m
No. of employees
196
News stories
From web sources and news partners
About Mega Genomics Ltd
CEO-
Employees196
Founded2016
Headquarters-
SectorHealth care provider
Websitemegagenomics.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
82,93 m
82,93 m
96,25 m
96,25 m
Cost of goods sold
54,32 m
54,32 m
64,41 m
64,41 m
Cost of revenue
54,32 m
54,32 m
64,41 m
64,41 m
Research and development expenses
8,65 m
8,65 m
3,56 m
3,56 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,62 m
16,62 m
12,59 m
12,59 m
Operating expense
30,06 m
30,06 m
17,35 m
17,35 m
Total operating expenses
84,38 m
84,38 m
81,76 m
81,76 m
Operating income
-1,45 m
-1,45 m
14,49 m
14,49 m
Other non operating income
305,00 k
305,00 k
193,00 k
193,00 k
EBT including unusual items
-157,50 k
-157,50 k
15,48 m
15,48 m
EBT excluding unusual items
36,00 k
36,00 k
15,48 m
15,48 m
Income tax expense
-37,50 k
-37,50 k
3,11 m
3,11 m
Effective tax rate
23,81%
23,81%
20,06%
20,06%
Other operating expenses
577,00 k
577,00 k
-
-
Net income
-120,00 k
-120,00 k
12,38 m
12,38 m
Net profit margin
-0,14%
-0,14%
12,86%
12,86%
Earnings per share
-
-
-
-
Interest and investment income
1,59 m
1,59 m
1,04 m
1,04 m
Interest expense
-419,00 k
-419,00 k
-289,50 k
-289,50 k
Net interest expenses
1,17 m
1,17 m
747,50 k
747,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
871,50 k
871,50 k
16,76 m
16,76 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme